Pharmaceuticals sector

Novartis stock falls nearly 4% as heart-drug failure deepens setbacks

Swiss drugmaker Novartis’ latest twin disappointments follow the success of its multiple sclerosis pill remibrutinib in two late-stage trials.

New Zealand approves use of party drug MDMA to treat trauma

New Zealand’s Deputy Prime Minister David Seymour said the country is committed to opening up access to “innovative treatments”.

Snoring, subways and stealth ads: How big pharma targets China's waistline

China’s rate of overweight or obese people could reach more than 65 per cent by 2030, the country’s National Health Commission has said.

‘No discussions’ over AstraZeneca-Bristol Myers deal, senior source says

Reports said that the two drugmakers had held preliminary talks about a possible deal that would create a pharmaceutical behemoth with a combined value of nearly US$400 billion.

While You Were Sleeping: 5 stories you might have missed, Aug 3, 2026

Firefighters battle a wildfire near the Agia Paraskevi village, Greece, on Aug 2, 2026.

Pharma giants AstraZeneca, Bristol Myers Squibb in talks on $512 billion mega deal: Report

The report of the potential deal comes about a dozen years after AstraZeneca fended off a takeover attempt by larger US rival Pfizer.

India takes action against 90% of inspected high-risk pharmaceutical facilities: Regulator

The crackdown is part of a broader effort to strengthen quality standards in India after Indian-made cough syrups were linked by global health authorities to child deaths.

Johnson & Johnson reaches sweeping talc deal that could end decade of litigation

The settlement covers claims alleging that Johnson & Johnson’s talc products cause ovarian cancer.

US panel backs trendy peptides despite safety concerns

The peptides are popular in wellness circles but lack strong clinical evidence.

Trump plans 100% tariff on generic drugs from August 2028

Levies on drugs would double to 200 per cent in 2029, said the US president.

E-paper

Newsletters

Podcasts

RSS Feed

About Us

Terms & Conditions

Personal Data Protection Notice

Need help? Reach us here.

Advertise with us

MDDI (P) 046/10/2025. Published by SPH Media Limited, Co. Regn. No.202120748H. Copyright © 2026 SPH Media Limited. All rights reserved.